心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

艾司洛尔注射液抗心律失常中国专家建议

2021-04-10 中国生物医学工程学会心律学分会 中华内科杂志.2021.60(4):314-320.

抗心律失常药

β受体阻滞剂是多种心血管疾病的治疗基石，艾司洛尔作为超短效作用的静脉β受体阻滞剂，具有起效迅速、代谢快、方便调控的特点，是心律失常急性期治疗的重要药物。艾司洛尔阻断交感神经兴奋，具

中文标题：

艾司洛尔注射液抗心律失常中国专家建议

发布机构：

中国生物医学工程学会心律学分会

发布日期：

2021-04-10

简要介绍：

β受体阻滞剂是多种心血管疾病的治疗基石，艾司洛尔作为超短效作用的静脉β受体阻滞剂，具有起效迅速、代谢快、方便调控的特点，是心律失常急性期治疗的重要药物。艾司洛尔阻断交感神经兴奋，具有负性肌力、负性频率、降低血压等多重作用，临床应用时常面临既有适应证又有相对禁忌证的情况，需掌握好适应证和禁忌证，规范合理用药。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=艾司洛尔注射液抗心律失常中国专家建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cb5ed1c002085936, title=艾司洛尔注射液抗心律失常中国专家建议, enTitle=, guiderFrom=中华内科杂志.2021.60(4):314-320., authorId=0, author=, summary=&beta;受体阻滞剂是多种心血管疾病的治疗基石，艾司洛尔作为超短效作用的静脉&beta;受体阻滞剂，具有起效迅速、代谢快、方便调控的特点，是心律失常急性期治疗的重要药物。艾司洛尔阻断交感神经兴奋，具, cover=https://img.medsci.cn/2021423/1619189213967_2020535.jpg, journalId=0, articlesId=null, associationId=438, associationName=中国生物医学工程学会心律学分会, associationIntro=先后共成立了工程学组、电生理学组、起搏学组、儿科学组、药理学组、地市培训学组等六个学组。 每两年举办一届中国心脏起搏与电生理学术年会，至今已举办十四届（中国心律学论坛）。并出版了《中国心律学》（人卫出版） 2008，2009和2010三本系列专著。 2001年成功地举办了四年一次的第七届亚太心脏起搏与电生理大会。会议有53个国家和地区 380名外宾和1200名国内专家和代表参加。368篇文摘刊登在美国《PACE》专业杂志，并出版了会议专集，另外有357篇刊登在国内印制的会议论文汇编上。 2002年全国近40个心律失常专家在京召开了&ldquo;射频消融治疗快速心律失常指南修改&rdquo;会议。 全国射频消融治疗快速心律失常注册： 自1996年中国生物医学工程学会心脏起搏与电生理分会首次在全国注册射频消融治疗快速心律失常资料以来，每年坚持完成注册登记工作。 &ldquo;离子通道病全国注册协作&rdquo;研究： 长QT综合征全国协作小组于 1999年成立为进一步促进国内的研究，了解研究动态，实现资源共享，将注册的病种扩大到全部的离子通道病，成立了离子通道病全国注册及国际协作研究小组，并邀请国际上该领域的知名专家共同进行中国的离子通道病研究。 自2010年学会牵头开展了&ldquo;J综合征注册研究&rdquo;和&ldquo;校园猝死高危人群筛查和防治&rdquo;, copyright=0, guiderPublishedTime=Sat Apr 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>&beta;受体阻滞剂是多种心血管疾病的治疗基石，艾司洛尔作为超短效作用的静脉&beta;受体阻滞剂，具有起效迅速、代谢快、方便调控的特点，是心律失常急性期治疗的重要药物。艾司洛尔阻断交感神经兴奋，具有负性肌力、负性频率、降低血压等多重作用，临床应用时常面临既有适应证又有相对禁忌证的情况，需掌握好适应证和禁忌证，规范合理用药。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=44199, tagName=抗心律失常药)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=44199, guiderKeyword=抗心律失常药, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5308, appHits=269, showAppHits=0, pcHits=1079, showPcHits=5039, likes=2, shares=26, comments=17, approvalStatus=1, publishedTime=Fri Apr 23 23:07:59 CST 2021, publishedTimeString=2021-04-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 23 22:46:59 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 20:44:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=艾司洛尔注射液抗心律失常中国专家建议.pdf)])
艾司洛尔注射液抗心律失常中国专家建议.pdf
下载请点击：
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1084934, encodeId=1bba1084934b5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5442401149, createdName=12354be1m20暂无昵称, createdTime=Mon Dec 27 23:20:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084042, encodeId=536010840427a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Fri Dec 24 21:46:33 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065142, encodeId=eec8106514205, content=需要好好学习领悟, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:22:24 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061111, encodeId=717c1061111e2, content=OK, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42925140675, createdName=14676501m26(暂无昵称), createdTime=Sat Oct 16 21:50:46 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977741, encodeId=ed829e774113, content=扣积分，应该赏积分才对啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/fbb42f63ff8642ae80827e5e0105171d/da8c7239bbcc4858920ca1cee0cb3a8e.jpg, createdBy=10785536423, createdName=关平, createdTime=Mon Jun 28 22:44:17 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-12-27 12354be1m20暂无昵称

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1084934, encodeId=1bba1084934b5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5442401149, createdName=12354be1m20暂无昵称, createdTime=Mon Dec 27 23:20:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084042, encodeId=536010840427a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Fri Dec 24 21:46:33 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065142, encodeId=eec8106514205, content=需要好好学习领悟, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:22:24 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061111, encodeId=717c1061111e2, content=OK, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42925140675, createdName=14676501m26(暂无昵称), createdTime=Sat Oct 16 21:50:46 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977741, encodeId=ed829e774113, content=扣积分，应该赏积分才对啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/fbb42f63ff8642ae80827e5e0105171d/da8c7239bbcc4858920ca1cee0cb3a8e.jpg, createdBy=10785536423, createdName=关平, createdTime=Mon Jun 28 22:44:17 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-12-24 坚定的心

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1084934, encodeId=1bba1084934b5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5442401149, createdName=12354be1m20暂无昵称, createdTime=Mon Dec 27 23:20:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084042, encodeId=536010840427a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Fri Dec 24 21:46:33 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065142, encodeId=eec8106514205, content=需要好好学习领悟, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:22:24 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061111, encodeId=717c1061111e2, content=OK, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42925140675, createdName=14676501m26(暂无昵称), createdTime=Sat Oct 16 21:50:46 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977741, encodeId=ed829e774113, content=扣积分，应该赏积分才对啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/fbb42f63ff8642ae80827e5e0105171d/da8c7239bbcc4858920ca1cee0cb3a8e.jpg, createdBy=10785536423, createdName=关平, createdTime=Mon Jun 28 22:44:17 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-10-30 1e1366a1m07(暂无匿称)

    需要好好学习领悟

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1084934, encodeId=1bba1084934b5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5442401149, createdName=12354be1m20暂无昵称, createdTime=Mon Dec 27 23:20:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084042, encodeId=536010840427a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Fri Dec 24 21:46:33 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065142, encodeId=eec8106514205, content=需要好好学习领悟, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:22:24 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061111, encodeId=717c1061111e2, content=OK, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42925140675, createdName=14676501m26(暂无昵称), createdTime=Sat Oct 16 21:50:46 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977741, encodeId=ed829e774113, content=扣积分，应该赏积分才对啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/fbb42f63ff8642ae80827e5e0105171d/da8c7239bbcc4858920ca1cee0cb3a8e.jpg, createdBy=10785536423, createdName=关平, createdTime=Mon Jun 28 22:44:17 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-10-16 14676501m26(暂无昵称)

    OK

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1084934, encodeId=1bba1084934b5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5442401149, createdName=12354be1m20暂无昵称, createdTime=Mon Dec 27 23:20:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084042, encodeId=536010840427a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/d7aef29f1c284560b978861e2a96fbb2/c495254e3ce54350a8a4f1eb91e884c8.jpg, createdBy=15e55464744, createdName=坚定的心, createdTime=Fri Dec 24 21:46:33 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065142, encodeId=eec8106514205, content=需要好好学习领悟, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sat Oct 30 00:22:24 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061111, encodeId=717c1061111e2, content=OK, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42925140675, createdName=14676501m26(暂无昵称), createdTime=Sat Oct 16 21:50:46 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977741, encodeId=ed829e774113, content=扣积分，应该赏积分才对啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/fbb42f63ff8642ae80827e5e0105171d/da8c7239bbcc4858920ca1cee0cb3a8e.jpg, createdBy=10785536423, createdName=关平, createdTime=Mon Jun 28 22:44:17 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-06-28 关平

    扣积分，应该赏积分才对啊

    0

以上为热门评论，梅斯医学App还有更多内容